Abstract:The HACOR scale variables are easily obtained at the bedside. The scale appears to be an effective way of predicting NIV failure in hypoxemic patients. Early intubation in high-risk patients may reduce hospital mortality.
“…In a recent article in this journal, Duan and co-workers [17] presented the HACOR score (heart rate, acidosis, consciousness, oxygenation, respiratory rate), based on five variables easily assessed in the emergency room, to predict, in patients with hypoxemic ARF treated with NIV, the need for intubation. The score was first tested and subsequently validated in two cohorts of patients.…”
“…In a recent article in this journal, Duan and co-workers [17] presented the HACOR score (heart rate, acidosis, consciousness, oxygenation, respiratory rate), based on five variables easily assessed in the emergency room, to predict, in patients with hypoxemic ARF treated with NIV, the need for intubation. The score was first tested and subsequently validated in two cohorts of patients.…”
“…However, patients less than 18 years old were excluded. NIV (BiPAP Vision or V60; Philips Respironics, Carlsbad, CA) was initiated by the attending physicians based on the indications described previously [16,17]. In patients with chronic obstructive pulmonary disease (COPD), the indications for NIV were respiratory rate more than 25 breaths/min, PaCO 2 more than 45 mmHg, pH less than 7.35, PaO 2 /FiO 2 less than 200 mmHg, and vigorous activity of accessory respiratory muscles.…”
Background: Knowledge of delirium in noninvasive ventilation (NIV) is lacking. We aimed to report the incidence, characteristics and outcomes of delirium in NIV patients. Methods: A prospective observational study was performed in an intensive care unit (ICU) of a teaching hospital. Patients who used NIV as a fist-line intervention were enrolled. During NIV intervention, delirium was screened using Confusion Assessment Method for the ICU every day. Results: We enrolled 1083 patients. Of them, 196 patients (18.1%) experienced delirium during NIV intervention. Patients with delirium had higher NIV failure rates (37.8% vs. 21.0%, p <0.01), higher ICU mortality (33.2% vs. 14.3%, p <0.01) and higher hospital mortality (37.2% vs. 17.0%, p <0.01) than the subjects without delirium. They also spent longer time on NIV (median 6.3 vs. 3.7 days, p <0.01), and stayed longer in ICU (median 9.0 vs. 6.0 days, p <0.01) and hospital (median 14.5 vs. 11.0 days, p <0.01). Furthermore, delirium was independently associated with NIV failure, ICU mortality and hospital mortality (OR =1.97, 2.58 and 2.55, respectively; all p values <0.01). These results were confirmed in COPD and non-COPD cohorts. Compared with hyperactive delirium patients, the NIV days was longer in hypoactive delirium patients and much longer in mixed delirium patients (median 3.4 vs. 6.5 vs. 10.1 days, p <0.01). Similar outcomes were found in the length of stay in ICU and hospital. However, the NIV failure, ICU mortality and hospital mortality did not differ between three subtypes of delirium.Conclusions: Delirium increases the NIV failure rates, elevates the ICU and hospital mortality, prolongs the NIV days, and lengthens the ICU and hospital stay. Mixed delirium patients use more ICU resources than hypoactive delirium patients and much more than hyperactive delirium patients.
“…Por tanto, no recomendamos la utilización de SRNI en estos pacientes 1,20,21 . Solo se podría plantear en pacientes muy seleccionados, siempre y cuando se cumplan todos los siguientes criterios 19,[21][22][23][24][25][26][27] :…”
publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.Cómo citar este artículo: Cinesi Gómez C, et al. Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.